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Overview 
The role of emotion within CBT for psychosis (CBTp) has evolved as treatment 
research and clinical practice has progressed over the past three decades. For 
example, early case reports framed emotions such as anxiety as a downstream 
consequence of delusional thinking. Similarly, most CBTp goal setting guidance 
emphasized that treatment need should follow the distress and interference caused by 
symptoms, not their mere presence. Yet, it has become clearer that emotional 
dysregulation may act as an upstream driver of psychosis, with the possibility it has a 
strong role to play in causing distressing mental experiences.  These observations 
have unfolded alongside the emergence of the third wave of behaviour therapy 
approaches. With this we have seen renewed interest in understanding the mediators 
and moderators of clinical improvement along with a greater focus on the 
transdiagnostic processes that govern the development and maintenance of problems 
of emotion, cognition, and behaviour. As a result, we now have more refined 
therapeutic targets (e.g. specific symptom experiences such as anhedonia), new 
 
clinical formulations (e.g. transdiagnostic accounts of how anxiety processes such as 
worry affect symptom development and maintenance), and new treatment techniques 
(e.g. mindfulness based approaches). Some of these trends, findings, and future 
directions for CBTp are presented below.  
 
Major Findings 
CBTp has undergone a remarkable transformation from something of a curiosity in 
the early 1990s to its modern day status as a major branch of applied therapy research. 
We now know that talking to people about their hallucinations and delusions does not 
make them worse, and in many cases it may help them to process and make sense of 
their experiences in a more adaptive way. We have also learned that there is not really 
a monolithic entity that we can call CBTp. The proliferation of meta-analyses have 
shown that the family tree of CBTp has many branches across the dimensions of 
treatment target (command hallucinations vs. all symptoms), stage of illness (early 
psychosis vs. long standing experiences) and style of intervention (e.g. highly 
behavioural vs. very cognitive). Outcome data across CBTp trials also shows that a 
treatment response can occur in domains not directly targeted as part of the 
intervention protocol. For example, secondary outcomes such as depression and social 
anxiety can improve even when these have not been targeted for change. Following 
these data, emotional processes have become important targets for intervention in 
newer generation CBTp protocols. Processes such as worry, rumination, traumatic 
memory retrieval, and experiential avoidance are now the focus of empirical testing 
and evaluation in experimental work and trial contexts. This work has also stimulated 
the adoption of treatment manoeuvres that may have previously been considered 
 
irrelevant or too difficult to implement in the context of psychosis (e.g. metacognitive 
strategies).  
 
 
Clinical Implications. 
Psychological therapies are increasingly recognised as a mandatory component of 
good quality care for people experiencing psychosis but there is much still to do. 
First, we need better models of specific problematic experiences faced by people with 
psychosis. In many ways we are moving away from the era of “CBT for psychosis” 
into a more transdiagnostic phase where the processes underpinning specifiable 
problems are identified and then used to drive problem focused psychological 
formulations and treatment plans. Prominent emerging transdiagnostic problem 
targets include suicidality, anhedonia, loss of meaning and purpose, and depressed 
mood. Traditional psychotic symptoms such as hallucinations and delusions will still 
warrant therapeutic attention for many people experiencing psychosis; however, the 
next generation of treatment approaches need to be more closely matched to the 
processes underpinning these problems and their functional consequences. For 
instance, while symptom elimination may remain a chosen goal for some people, 
others may be better served by learning new ways of relating more productively to 
their mind and living well in the presence of symptoms. Also, while distraction and 
behavioural coping based strategies may help many people manage harmful symptom 
experiences in the short term, long term and generalized improvements in functioning 
will most probably require development of a deeper understanding of ones own mind 
and its vagaries. The techniques in third wave approaches that shape up more adaptive 
ways of reacting to our mental experiences focus therapeutic attention on promoting 
 
skills that support autonomy, self-determination, and the pursuit of a personally 
meaningful life.  
 
 
Future Directions 
The move by NIMH to determine funding allocations on Research Domain Criteria 
(RDoC) instead of DSM diagnoses has stimulated new conversations about the best 
way to understand and treat mental health problems. This has helped dissolve 
arbitrary dichotomies between neurosis and psychosis, and has supported moves 
toward transdiagnostic approaches to formulation and treatment. However, the RDoC 
approach has drawn criticism for being overly focused on neuroscience research and 
reductionist models of illness. Hence, there is a need for robust psychological models 
that understand psychosis in context, and can play a major part in shaping better and 
more effective care.  This endeavour may also be helped by using new concepts such 
as stratified medicine to drive innovative thinking in understanding mental ill health 
in a personalized and targeted way. As evidence of these developments, therapy 
protocols are beginning to emerge that target specific sub-types of symptoms that 
trouble many people with psychosis such anhedonia, and specific classes of 
hallucinations. These new applied research efforts will bring us closer to genuinely 
person-centred care that makes meaningful differences to the lives of those seeking 
psychological help.   
 
 
Further Readings 
Hershenberg, R., & Goldfried, M. R. (2015). Implications of RDoC for the research 
 
and practice of psychotherapy. Behavior Therapy. 
McCarthy-Jones, S., Thomas, N., Strauss, C., Dodgson, G., Jones, N., Woods, A., et 
al. (2014). Better Than Mermaids and Stray Dogs? Subtyping Auditory Verbal 
Hallucinations and Its Implications for Research and Practice. Schizophrenia 
Bulletin, 40 (Suppl 4), S275–S284.  
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. 
W., et al. (2014). Stratified medicine for mental disorders. European 
Neuropsychopharmacology, 24(1), 5–50.    
